Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial

Mukherjee, S.; Hurt, C.; Bridgewater, J.; Falk, S.; Cummins, S.; Wasan, H.; Crosby, T.; Jephcott, C.; Roy, R.; Radhakrishna, G.; Mcdonald, A.; Ray, Ruby; Joseph, G.; Staffurth, J.; Abrams, R.; Griffiths, G.; Maughan, T.

doi:10.1016/S1470-2045(13)70021-4

Public

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial

Shared by NobleBlocks on Apr 1, 2013 • 12:00 AM UTC

Authors:

S. Mukherjee

C. Hurt

J. Bridgewater

Abstract

Summary Background In the UK, chemotherapy is the standard treatment for inoperable, locally advanced, non-metastatic pancreatic cancer. Chemoradiotherapy is also an acceptable treatment option, for which gemcitabine, fluorouracil, or capecitabine can be used as concurrent chemotherapy agents. We ai...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!